Some Psoriasis Biologics Better Than Others for Preventing Progression to PsA

(MedPage Today) -- Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or IL-23 inhibitors compared with those receiving tumor necrosis factor (TNF) inhibitors, a single-center study...